Jones Financial Companies’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.2M Buy
172,385
+58,337
+51% +$10.4M 0.01% 490
2026
Q1
$18.2M Buy
114,048
+113,220
+13,674% +$21M 0.01% 626
2025
Q4
$165K Buy
828
+27
+3% +$4.9K ﹤0.01% 1996
2025
Q3
$119K Sell
801
-77
-9% -$12.2K ﹤0.01% 2010
2025
Q2
$132K Sell
878
-18
-2% -$2.4K ﹤0.01% 1825
2025
Q1
$139K Buy
896
+255
+40% +$42.8K ﹤0.01% 1632
2024
Q4
$118K Buy
641
+90
+16% +$17.3K ﹤0.01% 1563
2024
Q3
$109K Buy
551
+266
+93% +$55.3K ﹤0.01% 1362
2024
Q2
$58.9K Buy
285
+279
+4,650% +$63.2K ﹤0.01% 1191
2024
Q1
$1.63K Sell
6
-16
-73% -$3.82K ﹤0.01% 1274
2023
Q4
$5.2K Sell
22
-9
-29% -$1.77K ﹤0.01% 757
2023
Q3
$6.08K Buy
31
+6
+24% +$1.23K ﹤0.01% 507
2023
Q2
$5.26K Hold
25
﹤0.01% 490
2023
Q1
$5.05K Hold
25
﹤0.01% 519
2022
Q4
$5K Hold
25
﹤0.01% 536
2022
Q3
$5K Hold
25
﹤0.01% 473
2022
Q2
$5K Hold
25
﹤0.01% 541
2022
Q1
$7K Hold
25
﹤0.01% 543
2021
Q4
$9K Sell
25
-50
-67% -$19.4K ﹤0.01% 559
2021
Q3
$31K Buy
75
+50
+200% +$20.8K ﹤0.01% 380
2021
Q2
$9K Hold
25
﹤0.01% 478
2021
Q1
$7K Buy
+25
New +$6.95K ﹤0.01% 571

Other funds holding CRL

Jones Financial Companies's CRL Position: Q2 2026 in Review

Jones Financial Companies increased its Charles River Laboratories (CRL) stake by 51% in Q2 2026, buying an estimated $10.4M and bringing the position to 172,385 shares worth $37.2M. The position accounts for 0.01% of the portfolio, ranked #490.

Jones Financial Companies first reported a position in CRL in Q1 2021 and has held it in 22 quarters since. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Jones Financial Companies held 172,385 shares of Charles River Laboratories worth $37.2M as of Q2 2026.
  • Jones Financial Companies bought 58,337 Charles River Laboratories shares in Q2 2026, an estimated $10.4M.
  • Charles River Laboratories made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #490 holding.
  • Jones Financial Companies first reported a position in Charles River Laboratories in Q1 2021 and has held it in 22 quarters since.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.